1-7 of 7
Yajin Ni
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A single-arm, open-label, multi-center, phase 1b/2 Study to evaluate the safety, efficacy, and cellular pharmacokinetic profile of CTD402 in participants with relapsed/refractory T-cell acute lymphoblastic leukemia (T-ALL) and lymphoblastic lymphoma (T-LBL) (TENACITY-01)

Free
Lori Muffly, Edward Abadir, Mark Geyer, Ryan Cassaday, Gregory Roloff, R. Alejandro Sica, Wendy Stock, Eileen McNulty, Maria Del Rosario, Xiao Shi, Yanbo Liu, Yong Yu, Yali Zhou, Ming Gao, Wengang Ge, Lu Han, Yajin Ni, Jiangtao Ren, Jan Davidson-Moncada, Nitin Jain
Journal: Blood
Blood (2025) 146 (Supplement 1): 5954.
https://doi.org/10.1182/blood-2025-5954
Published: 2025
Journal Articles

CTD402, allogeneic anti-CD7 CAR t-cell, in relapsed or refractory (R/R) t-cell acute lymphoblastic leukemia/lymphoblastic lymphoma (T-ALL/LBL) - report of clinical outcomes at the recommended phase 2 dose (RP2D)

Free
Peihua Lu, Yong-xian Hu, Xian Zhang, Junfang Yang, Xiaoyu Zhu, Ying Wang, Keshu Zhou, Sanbin Wang, Jiang Cao, Heng Mei, Kai Hu, Yong Yu, Yali Zhou, Eileen McNulty, Ming Gao, Maria Delrosario, Wengang Ge, Yajin Ni, Jiangtao Ren, Jan Davidson-Moncada, He Huang
Journal: Blood
Blood (2025) 146 (Supplement 1): 1042.
https://doi.org/10.1182/blood-2025-1042
Published: 2025
Journal Articles

CTD402: Allogeneic CAR-t manufacturing that overcomes donor- & process-derived variation with robust clinical activity

Free
Xiaojing Zhang, Liping Zhu, Mengyao Wang, Shuhui Yu, Yu Liu, Mingxi Chen, Yanbo Liu, Yong Yu, Maria del Rosario, Wengang Ge, Jan Davidson-Moncada, Yajin Ni, Jiangtao Ren
Journal: Blood
Blood (2025) 146 (Supplement 1): 4180.
https://doi.org/10.1182/blood-2025-4180
Published: 2025
Journal Articles

Target enrichment long-range sequencing (TLES) reveals structural variations missed by PEM-seq

Free
Shuhui Yu, Yueqiang Wang, Wenxin Zhu, Qin Chen, Biao Wang, Qiang Wu, Yali Zhou, Ling Yuan, Sha Li, Xiaojing Zhang, Mingxi Chen, Mengyao Wang, Liping Zhu, Yajin Ni, Jan Davidson-Moncada, Jiangtao Ren
Journal: Blood
Blood (2025) 146 (Supplement 1): 4122.
https://doi.org/10.1182/blood-2025-4122
Published: 2025
Journal Articles

ALLO-715, an Allogeneic BCMA CAR T Therapy Possessing an Off-Switch for the Treatment of Multiple Myeloma

Free
Cesar Sommer, PhD, Bijan Boldajipour, PhD, Julien Valton, PhD, Roman Galetto, PhD, Trevor Bentley, Janette Sutton, Yajin Ni, PhD, Mark Leonard, PhD, Thomas Van Blarcom, PhD, Julianne Smith, PhD, Javier Chaparro-Riggers, PhD, Barbra Sasu, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 591.
https://doi.org/10.1182/blood-2018-99-119227
Published: 2018
Journal Articles

CD86 and CD54 Co-Expression on VSV-G Pseudotyped HIV-1 Based Vectors Improves Transduction and Activation of Human Primary CD4+ T Lymphocytes.

Free
Brian Paszkiet, MA, Andrew Worden, Yajin Ni, PhD, Saran Bao, BA, Franck Lemiale, PhD, PharmD, Boro Dropulic, PhD, Laurent Humeau, PhD
Journal: Blood
Blood (2004) 104 (11): 1754.
https://doi.org/10.1182/blood.V104.11.1754.1754
Published: 2004
Journal Articles

ABC transporter inhibitors that are substrates enhance lentiviral vector transduction into primitive hematopoietic progenitor cells

Free
Brian M. Davis, Laurent Humeau, Vladimir Slepushkin, Gwendolyn Binder, Lauren Korshalla, Yajin Ni, E. Oluwakemi Ogunjimi, Lan-Fei Chang, Xiaobin Lu, Boro Dropulic
Journal: Blood
Blood (2004) 104 (2): 364–373.
https://doi.org/10.1182/blood-2003-07-2363
Published: 2004